Baloxavir Marboxil is a first-in-class, oral anti-influenza virus drugthat inhibits the influenza virus cap-dependent endonuclease,blocking viral mRNA transcription and replication.
Approved Indications
Treatment of acute uncomplicated influenza in adults and children aged ≥5 years
Post-exposure prophylaxis of influenza in people ≥5 years
Key Features
Single oral dose treatment
High efficacy against influenza A and B, including oseltamivir-resistant strains
Rapid reduction of viral load and symptom duration
Novel mechanism of action
Applications
API, intermediates, reference standards for R&D, generic registration and commercial production.
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
China [CN] 
Click enlarge Image